Evaluating Genomic Methods for Assessing Fecal Microbiota Transplant (FMT) Efficacy After Antibiotic Use
Abhinaya Muruganandham Background. Fecal microbiota transplantation (FMT) is a transformative therapy for restoring gut microbial ecology, particularly in treating recurrent Clostridioides difficile infection (rCDI) [1,2,3,4]. While highly successful for rCDI, its efficacy varies in other conditions like inflammatory bowel disease (IBD) or antibiotic-associated diarrhea [4]. Antibiotics significantly disrupt intestinal ecology,…